Bioreactor for Continuous Erythrocyte Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional methods for producing erythrocytes are inefficient, laborious, and unable to provide a continuous, on-site production of erythrocytes on a large scale, lacking the tissue-like physiologic environments necessary for normal cell expansion and differentiation.
Innovation Solution
A bioreactor system that expands hematopoietic cells from human placental perfusate and umbilical cord blood, allowing for continuous erythrocyte production by using a cell culture element, separation element, and gas provision, with optional feeder layers and immunomodulatory compounds to enhance cell expansion and differentiation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If conventional dish or flask-based culture systems are used, then cell culture can be performed, but they cannot handle single batches of >10^9 cells and require discontinuous medium exchange
Solution Approach 1:
The bioreactor system divides the culture process into distinct functional zones: a culture zone for cell expansion and a separation zone for continuous harvesting. This segmentation allows the system to handle large cell batches (>10^9 cells) by continuously removing differentiated cells, preventing overcrowding and enabling sustained production beyond the capacity of conventional dish-based systems.
Solution Approach 2:
The system implements continuous medium exchange and continuous cell separation/harvesting. The bioreactor continuously supplies fresh culture medium and simultaneously removes differentiated cells and debris, maintaining optimal culture conditions indefinitely. This continuous action eliminates the batch-wise operation limitations of conventional systems and enables sustained production of large cell quantities.
2Quantity of substance
If bag-type reactors are used to enlarge medium volume, then larger scale culture is possible, but significant media dilution and laborious 10-100 fold debulking are required
Solution Approach 1:
The bioreactor extracts and removes differentiated cells and culture debris continuously through its separation zone. By actively removing these components, the system maintains high cell density without requiring the massive medium volumes needed in bag-type reactors. This extraction approach eliminates the need for media dilution and subsequent debulking operations, directly producing concentrated erythrocyte products.
Solution Approach 2:
The system changes the operational parameters by maintaining high cell density throughout culture through continuous removal of differentiated cells. Unlike bag-type reactors that operate at low cell densities (2×10^6 to 6×10^6 cells/ml) requiring dilution, this bioreactor sustains high density conditions, enabling direct production of concentrated erythrocytes without debulking steps.
3Quantity of substance
If large-vessel stirred tank type bioreactors are used, then large scale production is possible, but they do not provide tissue-like physiologic environments conducive to normal cell expansion and differentiation
Solution Approach 1:
The bioreactor creates localized tissue-like microenvironments within its culture zone, providing physiological conditions that mimic in vivo environments. The system maintains appropriate oxygen gradients, nutrient distribution, and cell-cell interaction zones that promote normal hematopoietic differentiation. This local quality control ensures high-quality erythrocyte production while operating at scalable volumes, unlike large-vessel stirred tanks that create homogeneous but non-physiologic conditions.
4Quantity of substance
If conventional methods are used to produce erythrocytes, then production can be achieved, but the processes are inefficient, laborious, and cannot provide continuous on-site production
Solution Approach 1:
The bioreactor system operates continuously, simultaneously performing cell culture, differentiation, and separation functions. The continuous flow system constantly supplies nutrients, removes waste products, and harvests differentiated erythrocytes without interruption. This eliminates the sequential batch processing steps of conventional methods, dramatically reducing production time and enabling on-site continuous supply of erythrocytes.
Solution Approach 2:
The bioreactor integrates multiple functions into a single device: cell culture expansion, differentiation induction, and cell separation/harvesting all occur within one continuous system. This multi-functionality eliminates the need for separate culture vessels, differentiation chambers, and harvesting equipment required by conventional methods, streamlining the process into a single continuous operation that reduces both time and labor requirements.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioreactor system enables the efficient expansion and differentiation of hematopoietic cells into erythrocytes, achieving production levels comparable to current methods in a significantly smaller volume, with continuous or periodic collection, facilitating on-site production and administration.
Implementation Method 1
expanding a population of hematopoietic cells in the absence of a feeder layer
Implementation Method 2
differentiating the hematopoietic cells to erythrocytes or progenitors of erythrocytes
Implementation Method 3
the erythrocytes are collected by magnetic bead separation
Implementation Method 4
attracting the erythrocytes to a surface using a magnetic field
Implementation Method 5
partially or fully deoxygenating hemoglobin in said erythrocytes
Data Source
AI summary
Provided herein are methods of producing erythrocytes from hematopoietic cells, particularly hematopoietic cells from placental perfusate in combination with hematopoietic cells from umbilical cord blood, wherein the method results in accelerated expansion and differentiation of the hematopoietic cells to more efficiently produce administrable erythrocytes. Further provided herein is a bioreactor in which hematopoietic cell expansion and differentiation takes place.